RCCD1-AS1

Across TCGA pan-cancer cohorts, RCCD1-AS1 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of RCCD1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RCCD1-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RCCD1-AS1 is over-expressed in tumor.

HNSC, COAD, and BLCA are the cancer types where RCCD1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RCCD1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	III,IV	+0.307	<.001	12	view →
COAD	Female	II,III,IV	+0.501	<.001	11	view →
BLCA	Male	III,IV	+0.462	<.001	11	view →
LIHC	Female	II,III,IV	+0.220	<.001	9	view →
LUSC	Female	All	+0.443	<.001	6	view →
LUAD	Male	All	+0.282	<.001	6	view →
BRCA	All	II,III,IV	+0.177	<.001	6	view →
STAD	Male	II,III,IV	+0.367	<.001	4	view →
CHOL	Male	All	+0.878	<.001	3	view →
KIRC	Female	II,III,IV	+0.146	.005	3	view →
ESCA	All	II,III,IV	+0.595	.011	2	view →
UCEC	All	All	+0.240	.021	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

RCCD1-AS1–HNSC

Open the HNSC breakdown →